Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Genetix Biotherapeutics, formerly bluebird bio, develops one-time genetic therapies for sickle cell disease, β thalassemia, and cerebral adrenoleukodystrophy. Their treatments modify a patient's own blood stem cells to address the underlying genetic cause of these rare diseases.
Parse Score